http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3007090-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd088527d65ac18329cc8fd4e37d69e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f93c2bac4158236c95dadfc6616e3b08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_498134fbe172a722c3c1757493e943c1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
filingDate 2014-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0406a49b84a48c2ab3f7895e6a3e2ad3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_137430099b583652ed9e8dcf67c9c121
publicationDate 2016-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3007090-A1
titleOfInvention Immunogenic synthetic oligopeptides
abstract The present invention provides a method for producing immunogenic synthetic oligopeptides that are formed by minimal pentapeptide immune determinants uniquely present in antigens of interest and are useful for evoking specific, effective and non-crossreactive immune responses in immunotherapies and immunodiagnostics. n The invention also provides a pharmaceutical preparation, such as a vaccine, which comprises said immunogenic synthetic oligopeptides.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023022613-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021261993-A1
priorityDate 2014-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007111261-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID992
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID851455
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID50852
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33903
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2540183
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8627448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394197
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID107652
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443936
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396555
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID77647
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6675

Total number of triples: 34.